Suven Life Sciences' Stock Sees 7.03% Increase, Outperforms Sector on October 28
Suven Life Sciences, a smallcap pharmaceutical company, saw a 7.03% increase in its stock price on October 28, 2024. The company has a strong pipeline of products in various stages of development, with a focus on neurological disorders. Despite recent decline, Suven remains a promising player in the industry.
Suven Life Sciences, a smallcap pharmaceutical company, saw a 7.03% increase in its stock price on October 28, 2024. This rise was in line with the overall performance of the sector, as the company outperformed the sector by 6.18%.
The stock of Suven Life Sciences reached an intraday high of Rs 123.15, showing a 7.6% increase. However, the stock is currently trading lower than its 20-day, 50-day, and 100-day moving averages, but higher than its 5-day and 200-day moving averages.
In comparison to the Sensex, Suven Life Sciences' stock performance was much higher, with a 1-day performance of 7.03% compared to Sensex's 1.22%. However, over the past month, the company's stock has seen a decline of 15.05%, while the Sensex has only seen a decline of 6.08%.
Suven Life Sciences is a smallcap company in the pharmaceutical industry. The company has been making strides in the industry with its innovative research and development in drug discovery and development. With a focus on neurological disorders, the company has a strong pipeline of products in various stages of development.
Despite the recent decline in stock price, Suven Life Sciences remains a promising player in the pharmaceutical industry. Investors should keep an eye on the company's future developments and performance in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
